Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 2.36
- Piotroski Score 7.00
- Grade Outperform
- Symbol (ICLR)
- Company ICON Public Limited Company
- Price $212.65
- Changes Percentage (4.41%)
- Change $8.98
- Day Low $204.00
- Day High $213.37
- Year High $347.72
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/19/2025
- Fiscal Year End N/A
- Average Stock Price Target $317.50
- High Stock Price Target $390.00
- Low Stock Price Target $215.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $8.24
- Trailing P/E Ratio 38.75
- Forward P/E Ratio 38.75
- P/E Growth 38.75
- Net Income $612.34 M
Income Statement
Quarterly
Annual
Latest News of ICLR
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Icon PLC (ICLR) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ...
Steve Cutler, CEO of a biotech company, discusses the uncertain state of biotech demand and recovery pace. While optimistic about long-term prospects, the next few quarters remain unpredictable due to...
By Yahoo! Finance | 3 weeks ago -
Is There An Opportunity With ICON Public Limited Company's (NASDAQ:ICLR) 32% Undervaluation?
ICLR's intrinsic value estimated at US$365, 18% below its fair value. A Discounted Cash Flow (DCF) model was used to calculate this, considering future cash flows and discounting them....
By Yahoo! Finance | 2 months ago -
ICON Public Limited Company (ICLR) Stock Price, News, Quote & History - Yahoo Finance
ICON Public Limited Company is a clinical research organization offering development services globally, specializing in clinical trials, data solutions, and laboratory services for pharmaceutical, bio...
By Yahoo! Finance | 4 months ago
